RIL
IBRX icon

Rothschild Investment LLC’s ImmunityBio IBRX Stock Holding History

Rothschild Investment LLC’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54K Sell
290
-35
-11% -$265 ﹤0.01% 2651
2026
Q1 		$2.49K Buy
325
+323
+16,150% +$2.21K ﹤0.01% 2444
2025
Q4 		$4 Sell
2
-58
-97% -$131 ﹤0.01% 3408
2025
Q3 		$148 Sell
60
-695
-92% -$1.79K ﹤0.01% 3035
2025
Q2 		$1.99K Buy
755
+340
+82% +$914 ﹤0.01% 2086
2025
Q1 		$1.25K Buy
415
+330
+388% +$1K ﹤0.01% 2210
2024
Q4 		$218 Sell
85
-95
-53% -$396 ﹤0.01% 2775
2024
Q3 		$670 Buy
180
+95
+112% +$440 ﹤0.01% 2386
2024
Q2 		$537 Buy
85
+60
+240% +$396 ﹤0.01% 1965
2024
Q1 		$134 Buy
+25
New +$113 ﹤0.01% 1998

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rothschild Investment LLC's IBRX Position: Q2 2026 in Review

Rothschild Investment LLC reduced its ImmunityBio (IBRX) stake by 11% in Q2 2026, selling an estimated $265 and leaving 290 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Rothschild Investment LLC first reported a position in IBRX in Q1 2024 and has held it in 10 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Rothschild Investment LLC held 290 shares of ImmunityBio worth $2.54K as of Q2 2026.
  • Rothschild Investment LLC sold 35 ImmunityBio shares in Q2 2026, an estimated $265.
  • ImmunityBio made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2651 holding.
  • Rothschild Investment LLC first reported a position in ImmunityBio in Q1 2024 and has held it in 10 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.